View clinical trials related to VHL Gene Inactivation.
Filter by:This study is designed to investigate belzutifan as a treatment for VHL disease associated RCC.
The primary objective of this study is to assess the overall response rate (ORR) of von Hippel-Lindau (VHL) disease-associated clear cell renal cell carcinoma (ccRCC) tumors in VHL patients treated with PT2385.